GSK Plc (GLAXF)
25.56
+0.06
(+0.25%)
USD |
OTCM |
Aug 24, 16:00
GSK 1 Year Total Returns (Daily) : 33.01% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 33.01% |
| August 21, 2026 | 32.67% |
| August 20, 2026 | 33.82% |
| August 19, 2026 | 35.22% |
| August 18, 2026 | 36.38% |
| August 17, 2026 | 36.38% |
| August 14, 2026 | 38.27% |
| August 13, 2026 | 38.09% |
| August 12, 2026 | 37.74% |
| August 11, 2026 | 42.37% |
| August 10, 2026 | 42.75% |
| August 07, 2026 | 47.78% |
| August 06, 2026 | 47.78% |
| August 05, 2026 | 44.28% |
| August 04, 2026 | 34.13% |
| August 03, 2026 | 40.31% |
| July 31, 2026 | 36.13% |
| July 30, 2026 | 38.42% |
| July 29, 2026 | 44.26% |
| July 28, 2026 | 45.54% |
| July 27, 2026 | 45.94% |
| July 24, 2026 | 40.66% |
| July 23, 2026 | 45.13% |
| July 22, 2026 | 41.52% |
| July 21, 2026 | 55.88% |
| Date | Value |
|---|---|
| July 20, 2026 | 55.88% |
| July 17, 2026 | 48.02% |
| July 16, 2026 | 39.48% |
| July 15, 2026 | 40.38% |
| July 14, 2026 | 41.19% |
| July 13, 2026 | 41.19% |
| July 10, 2026 | 37.47% |
| July 09, 2026 | 37.47% |
| July 08, 2026 | 41.25% |
| July 07, 2026 | 47.86% |
| July 06, 2026 | 42.79% |
| July 02, 2026 | 40.57% |
| July 01, 2026 | 40.98% |
| June 30, 2026 | 39.61% |
| June 29, 2026 | 40.80% |
| June 26, 2026 | 41.05% |
| June 25, 2026 | 36.28% |
| June 24, 2026 | 43.83% |
| June 23, 2026 | 44.94% |
| June 22, 2026 | 36.70% |
| June 18, 2026 | 31.25% |
| June 17, 2026 | 39.55% |
| June 16, 2026 | 30.89% |
| June 15, 2026 | 26.01% |
| June 12, 2026 | 31.61% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| AstraZeneca PLC | 4.72% |
| Hikma Pharmaceuticals Plc | -4.84% |
| Allergy Therapeutics Plc | 76.47% |
| Shield Therapeutics Plc | -36.23% |
| Futura Medical Plc | -96.02% |